PCIG vs. PJP ETF Comparison

Comparison of Polen Capital International Growth ETF (PCIG) to PowerShares Dynamic Pharmaceuticals (PJP)
PCIG

Polen Capital International Growth ETF

PCIG Description

PCIG aims to deliver sustainable, above-average earnings growth and long-term stock price appreciation within the global ex-US equity market. The strategy is rooted in fundamental research, selecting 25-35 large-cap growth companies with a sustainable edge like consistent earnings growth, robust balance sheets, and shareholder-oriented management teams. Such companies are selected within industries characterized by high barriers to entry, such as those requiring substantial capital investment, government approvals, or significant intellectual property. Moreover, it integrates ESG factors into the investment process. While the fund may concentrate investments in the consumer discretionary and financial sectors, it avoids over-concentration in any one industry. Investments are typically held for the long term but are subject to period review and potential sale based on changing market conditions, company performance, or perceived threats to competitive advantage.

Grade (RS Rating)

Last Trade

$9.45

Average Daily Volume

5,905

Number of Holdings *

10

* may have additional holdings in another (foreign) market
PJP

PowerShares Dynamic Pharmaceuticals

PJP Description The PowerShares Dynamic Pharmaceuticals Portfolio (Fund) is based on the Dynamic Pharmaceutical IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Grade (RS Rating)

Last Trade

$85.66

Average Daily Volume

8,288

Number of Holdings *

25

* may have additional holdings in another (foreign) market
Performance
Period PCIG PJP
30 Days -4.03% -3.03%
60 Days -4.91% -3.63%
90 Days -4.78% -2.47%
12 Months 22.14%
0 Overlapping Holdings
Symbol Grade Weight in PCIG Weight in PJP Overlap
PCIG Overweight 10 Positions Relative to PJP
Symbol Grade Weight
ICLR D 10.24%
AON B 6.61%
MDT D 5.31%
MELI C 4.35%
HDB C 4.08%
SHOP B 3.84%
GLOB C 1.64%
UL D 1.28%
ONON B 0.89%
ACN B 0.82%
PCIG Underweight 25 Positions Relative to PJP
Symbol Grade Weight
ABT B -5.77%
JNJ D -5.29%
CORT B -5.29%
AMGN D -5.13%
PFE F -5.12%
ABBV F -4.91%
MRK F -4.79%
LLY F -4.67%
BMY B -4.07%
GILD B -4.0%
PBH A -3.82%
PCRX C -3.78%
UTHR C -3.7%
REGN F -3.69%
LGND C -3.63%
JAZZ B -3.62%
VTRS A -3.61%
AMRX C -3.55%
SUPN B -3.47%
INVA D -3.37%
ANIP D -3.12%
AMPH F -3.11%
PRGO C -3.08%
BIIB F -2.71%
GERN C -2.66%
Compare ETFs